← Eichor
Study identifier: NCT07447076 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

Condition: Recurrent Atypical Teratoid/Rhabdoid Tumor · Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS  ·  Sponsor: Sabine Mueller, MD, PhD

PhasePhase 2
Planned participants29
Who can joinAll sexes, 1 Year to 39 Years
Healthy volunteersNo

About this study

This is a multi-treatment arm study that will be conducted through the Pacific Pediatric Neuro-oncology Consortium (PNOC).The study will assess the safety and efficacy of novel therapies and combinatorial strategies for participants with recurrent or progressive ATRT.

This description comes directly from the study's public registry record.

Talk to the study team

PNOC Operations Office  ·  415-502-1600  ·  PNOC035@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (2)

University of California, San FranciscoSan Francisco, California, United StatesNot Yet Recruiting
University of California, San FranciscoSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07447076